Sucralfate

Overview

Sucralfate is a medication primarily used to treat active duodenal ulcers. It acts by forming a protective layer on the ulcer, which shields it from stomach acid and enzymes, allowing it to heal.

API suppliers (16)

Suppliers of Sucralfate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• ALIVUS LIFE SCIENCES LTDIndia2 active DMF GMP on record
• MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
• ARCHIMICA SPAItaly1 active DMF GMP on record
• THINQ PHARMA-CRO LTDIndia1 active DMF
• Gulbrandsen Technologies India Private LimitedIndia1 active DMF
• FUJI CHEMICAL INDUSTRIES CO LTDJapan1 active DMF
• SNJ LABS PVT LTDIndia1 active DMF
• Northeast Pharmaceutical Group Co., Ltd.China GMP on record
• SMITH KLINE & FRENCH LABS DIV SMITHKLINE BECKMAN CORP
• Unichem Laboratories Ltd.India GMP on record
• Orion CorporationFinland
• ORGAMOL SA
• Nippon Kayaku Co., Ltd.Japan GMP on record
• SHANGHAI NO 6 PHARMACEUTICAL FACTORY
• ISTITUTO CHEMICOTHERAPICO ITALIANO
• Nanjing Pharmaceutical Factory Co., Ltd.China

EU CEP holders (2)

Companies holding a valid EU Certificate of Suitability (CEP) for Sucralfate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas